Advanced search
Publication Cover
OncoTargets and Therapy Volume 12, 2019 - Issue
Submit an article Journal homepage
31
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis

Liming Wang1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Bo Chen2 Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Zhuo Li3 Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Xuesong Yao4 Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Mei Liu5 Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Weiqi Rong1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Fan Wu1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Shengtao Lin1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Yunhe Liu1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Yiling Zheng1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]
,
Yexiong Li2 Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
,
Weihu Wang6 Department of Radiation Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China, [email protected]Correspondence[email protected]
&
Jianxiong Wu1 Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [email protected]Correspondence[email protected]
 show all
Pages 1237-1247 | Published online: 15 Feb 2019

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lei Wang, Qiao Ke, Kongying Lin, Jingbo Chen, Ren Wang, Chunhong Xiao, Xiaolong Liu & Jingfeng Liu. (2020) Not All Hepatocellular Carcinoma Patients with Microvascular Invasion After R0 Resection Could Be Benefited from Prophylactic Transarterial Chemoembolization: A Propensity Score Matching Study. Cancer Management and Research 12, pages 3815-3825.
Read now

Articles from other publishers (15)

Liuhua Long, Bo Chen, Xuan Zheng, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu, Yexiong Li & Weihu Wang. (2024) Postoperative radiotherapy following null-margin hepatectomy in patients with hepatocellular carcinoma adhering to the major vessels: A propensity score-matched survival analysis cohort study. Clinical and Translational Radiation Oncology 45, pages 100727.
Crossref
Changcheng Tao, Kai Zhang, Zonggui Tao, Yue Liu, Anke Wu, Liming Wang, Qinfu Feng, Fan Wu, Weiqi Rong & Jianxiong Wu. (2023) Clinical benefits of intraoperative radiotherapy for the recurrence of centrally located hepatocellular carcinoma with microvascular invasion. Cancer Reports 7:1.
Crossref
Liuhua Long, Bo Chen, Hongzhi Wang, Yuting Zhao, Fan Wu, Liming Wang, Weiqi Rong, Jianxiong Wu, Yexiong Li & Weihu Wang. (2023) Survival benefit of radiotherapy following narrow-margin hepatectomy in patients with hepatocellular carcinoma: A propensity score-matched analysis based on phase II study. Radiotherapy and Oncology 180, pages 109462.
Crossref
小娟 贺. (2023) Advances in CT Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Advances in Clinical Medicine 13:05, pages 7454-7460.
Crossref
Lei Wang, Lu Qiu, Qiao Ke, Hongbing Ji & Junxin Wu. (2022) Systematic review of adjuvant external beam radiotherapy for hepatocellular carcinoma following radical hepatectomy. Radiotherapy and Oncology 175, pages 101-111.
Crossref
Dashuai Yang, Mingqiang Zhu, Xiangyun Xiong, Yang Su, Fangrui Zhao, Yong Hu, Guo Zhang, Junpeng Pei & Youming Ding. (2022) Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database. Frontiers in Oncology 12.
Crossref
Shilei Bai, Lei Hu, Jianwei Liu, Minmin Sun, Yanfu Sun & Feng Xue. (2022) Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus–related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection. Frontiers in Oncology 12.
Crossref
Zehao Zheng, Renguo Guan, Wang Jianxi, Zhen Zhao, Tianyi Peng, Chunsheng Liu, Ye Lin & Zhixiang Jian. (2022) Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive Management. Journal of Oncology 2022, pages 1-10.
Crossref
Jianqiang Cai, Jianjun Zhao, Defang Liu, Huangfan Xie, Hailong Qi, Junfan Ma, Zhongjie Sun & Hong Zhao. (2021) Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study. Frontiers in Oncology 11.
Crossref
Kai Zhang, Changcheng Tao, Tana Siqin, Jianxiong Wu & Weiqi Rong. (2021) Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion. Journal of Translational Medicine 19:1.
Crossref
Jiarui Yang, Hao Liang, Kunpeng Hu, Zhiyong Xiong, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao & Meihai Deng. (2021) The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis. Cancer Cell International 21:1.
Crossref
Bo Chen, Jian‐Xiong Wu, Shu‐Hui Cheng, Li‐Ming Wang, Wei‐Qi Rong, Fan Wu, Shu‐Lian Wang, Jing Jin, Yue‐Ping Liu, Yong‐Wen Song, Hua Ren, Hui Fang, Yuan Tang, Ning Li, Ye‐Xiong Li & Wei‐Hu Wang. (2021) Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC. Hepatology 74:5, pages 2595-2604.
Crossref
Wei Zhang, Bixiang Zhang & Xiao-ping Chen. (2021) Adjuvant treatment strategy after curative resection for hepatocellular carcinoma. Frontiers of Medicine 15:2, pages 155-169.
Crossref
Liming Wang, Weihu Wang, Weiqi Rong, Zhuo Li, Fan Wu, Yunhe Liu, Yiling Zheng, Kai Zhang, Tana Siqin, Mei Liu, Bo Chen & Jianxiong Wu. (2020) Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study. BMC Cancer 20:1.
Crossref
Jinghe Li, Xiu Xiong, Zuo Wang, Yufei Zhao, Zhengrong Shi, Ming Zhao & Tao Ren. (2020) In vitro high-throughput drug sensitivity screening with patient-derived primary cells as a guide for clinical practice in hepatocellular carcinoma—A retrospective evaluation. Clinics and Research in Hepatology and Gastroenterology 44:5, pages 699-710.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.